Infinity Pharmaceuticals, Inc. Increase (Decrease) in Deferred Revenue
Infinity Pharmaceuticals, Inc. reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-15
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$18.72M, a 189.44% decline from fiscal 2015.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2015 was $20.93M, a 80.97% decline from fiscal 2014.
- Infinity Pharmaceuticals, Inc. increase (decrease) in deferred revenue for fiscal 2014 was $110.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $0.00 derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | -$9.47M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | -$9.47M derived: sum of 3 quarters · filed 2018-03-15 | -$18.72M 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$9.47M derived: sum of 2 quarters · filed 2017-11-07 | -$18.72M 10-Q · filed 2017-11-07 | -$27.80M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$18.72M 10-Q · filed 2017-08-03 | -$27.80M derived: sum of 3 quarters · filed 2018-03-15 | $11.46M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | -$9.26M 10-Q · filed 2017-05-09 | -$18.33M derived: sum of 2 quarters · filed 2018-03-15 | $20.92M derived: sum of 3 quarters · filed 2018-03-15 | $16.04M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | -$9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $30.18M derived: sum of 2 quarters · filed 2018-03-15 | $25.30M derived: sum of 3 quarters · filed 2018-03-15 | $20.93M 10-K · filed 2018-03-15 |
| 2015-09-30 | $39.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $34.38M derived: sum of 2 quarters · filed 2016-11-09 | $30.01M 10-Q · filed 2016-11-09 | $25.66M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$9.24M 10-Q · filed 2016-08-09 | -$13.60M derived: sum of 3 quarters · filed 2017-03-14 | |
| 2015-03-31 | -$4.36M 10-Q · filed 2016-05-04 | -$8.72M derived: sum of 2 quarters · filed 2017-03-14 | ||
| 2014-12-31 | -$4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $110.00M 10-K · filed 2017-03-14 | ||
| 2014-09-30 | $114.36M 10-Q · filed 2015-11-05 | |||
| 2012-12-31 | -$38.89M 10-K · filed 2015-02-24 |